Trial intelligence / Profile preview

Remeron vs Psychotherapy for Interferon-related Depression

NCT01465919Phase 4Terminated

Sponsor
SMG-SNU Boramae Medical Center
Start
Aug 2011
Primary completion
Dec 2017
Countries
1
01

Overview

A Phase 4 trial of mirtazapine in major depressive disorder (MDD), sponsored by SMG-SNU Boramae Medical Center. Started Aug 2011; status: terminated.

02

Drugs

mirtazapine
03

Conditions

major depressive disorder (MDD)

Beyond the preview

Go deeper on NCT01465919.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01465919.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call